⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CMPX News
Compass Therapeutics, Inc. Common Stock
Compass Therapeutics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
globenewswire.com
CMPX
Form 8-K
sec.gov
CMPX
Tovecimig Demonstrates Statistically Significant Benefit in COMPANION-002 Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer
globenewswire.com
CMPX
Compass Therapeutics to Announce Topline Secondary Endpoints from the Phase 2/3 COMPANION-002 Study of Tovecimig in Patients with Biliary Tract Cancer
globenewswire.com
CMPX
CMP Pharma Announces Availability of a New Alcohol-Free Reformulation of Norliqva® (Amlodipine) Oral Solution
prnewswire.com
CMPX
Form 8-K
sec.gov
CMPX
Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update
globenewswire.com
CMPX
Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
prnewswire.com
CMPX
MRK
PFE
BOLD
REPL
RDHL
RLAY
LLY
INCY
JAZZ
The $185B Cancer Surge: Why the FDA's Fast-Track Pivot is Scaling a New Immunotherapy Era
globenewswire.com
ONCY
IBRX
BNTX
CMPX
Compass Therapeutics Provides Corporate Update
globenewswire.com
CMPX